SMAD‑6, ‑7 and ‑9 are potential molecular biomarkers for the prognosis in human lung cancer

MLA

Wentao Hu, et al. “SMAD‑6, ‑7 and ‑9 Are Potential Molecular Biomarkers for the Prognosis in Human Lung Cancer.” Oncology Letters, vol. 20, July 2020, pp. 2633–44. EBSCOhost, https://doi.org/10.3892/ol.2020.11851.

APA

Wentao Hu, Shuxian Pan, Guangming Zhou, & Hailong Pei. (2020). SMAD‑6, ‑7 and ‑9 are potential molecular biomarkers for the prognosis in human lung cancer. Oncology Letters, 20, 2633–2644. https://doi.org/10.3892/ol.2020.11851

Chicago

Wentao Hu, Shuxian Pan, Guangming Zhou, and Hailong Pei. 2020. “SMAD‑6, ‑7 and ‑9 Are Potential Molecular Biomarkers for the Prognosis in Human Lung Cancer.” Oncology Letters 20 (July): 2633–44. doi:10.3892/ol.2020.11851.